MedTrace Logo

Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome

NCT03118908 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2017-10-20

No results posted yet for this study

Summary

To evaluate effectiveness and safety of combined use of dietary supplements Amberen and Smart B by women with a typical (without complications) form of climacteric syndrome, with mild to moderate symptoms.

Conditions

Interventions

DIETARY_SUPPLEMENT

Amberen

Amberen is a succinate-based dietary supplement previously shown to help provide relief for common menopausal symptoms.

DIETARY_SUPPLEMENT

Smart B

Smart B contains vitamins B1, B2, B6, B9, B12 and sodium fumarate.

DIETARY_SUPPLEMENT

Placebo

Placebo capsules are identical to Amberen and Smart B capsules.

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
42 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-24
Primary Completion
2017-10-10
Completion
2017-10-10

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03118908 on ClinicalTrials.gov